Protective Effect of Donepezil on Retinal Ganglion Cells In Vitro and In Vivo

REFERENCES

• Rogers S L, Friedhoff L T. Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open label extension study. Eur Neuropsychopharmacol. 1998; 8: 67–75, [CSA]
   PubMed Web of Science ®Google Scholar
• Palmer A M. Pharmacotherapy for Alzheimer's disease: progress and prospects. Trends Pharmacol Sci. 2002; 23: 426–433, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Takada Y, Yonezawa A, Kume T, et al. Nicotinic acetylcholine receptor-mediated neuroprotection by donepezil against glutamate neurotoxicity in rat cortical neurons. J Pharmacol Exp Ther. 2003; 306: 772–777, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Akasofu S, Kosasa T, Kimura M, Kubota A. Protective effect of donepezil in a primary culture of rat cortical neurons exposed to oxygen-glucose deprivation. Eur J Pharmacol. 2003; 472: 57–63, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Krishnan K R, Charles H C, Doraiswamy P M, Mintzer J, Weisler R, Yu X, Perdomo C, Ieni J R, Rogers S. Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease. Am J Psychiatry. 2003; 160: 2003–2011, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• McKinnon S J, Lehman D M, Kerrigan-Baumrind L A, et al. Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension. Invest Ophthalmol Vis Sci. 2002; 43: 1077–1087, [CSA]
   PubMed Web of Science ®Google Scholar
• Bayer A U, Keller O N, Ferrari F, et al. Association of glaucoma with neurodegenerative diseases with apoptotic cell death: Alzheimer's disease and Parkinson's disease. Am J Ophthalmol. 2002; 133: 135–137, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Otori Y, Wei J Y, Barnstable C J. Neurotoxic effects of low doses of glutamate on purified rat retinal ganglion cells. Invest Ophthalmol Vis Sci. 1998; 39: 972–981, [CSA]
   PubMed Web of Science ®Google Scholar
• Otori Y, Kusaka S, Kawasaki A, Morimura H, Miki A, Tano Y. Protective effect of nilvadipine against glutamate neurotoxicity in purified retinal ganglion cells. Brain Res. 2003; 961: 213–219, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Tamai K, Toumoto E, Majima A. Local hypothermia protects the retina from ischaemic injury in vitrectomy. Br J Ophthalmol. 1997; 9: 789–794
   Google Scholar
• Romano C, Price M T, Almli T, Olney J W. Excitotoxic neurodegeneration induced by deprivation of oxygen and glucose in isolated retina. Invest Ophthalmol Vis Sci. 1998; 2: 416–423
   Google Scholar
• Adachi K, Kashii S, Masai H, Ueda M, Morizane C, Kaneda K, Kume T, Akaike A, Honda Y. Mechanism of the pathogenesis of glutamate neurotoxicity in retinal ischemia. Graefes Arch Clin Exp Ophthalmol. 1998; 10: 766–774, [CSA], [CROSSREF]
   Google Scholar
• Izumi Y, Hammerman S B, Kirby C O, Benz A M, Olney J W, Zorumski C F. Involvement of glutamate in ischemic neurodegeneration in isolated retina. Vis Neurosci. 2003; 2: 97–107, [CSA], [CROSSREF]
   Google Scholar
• Osborne N N, Ugarte M, Chao M, Chidlow G, Bae J H, Wood J P, Nash M S. Neuroprotection in relation to retinal ischemia and relevance to glaucoma. Surv Ophthalmol. 1999; 43: S102–128, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Lipton S A. Possible role for memantine in protecting retinal ganglion cells from glaucomatous damage. Surv Ophthalmol. 2003; 48(Suppl 1)S38–S46, [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Quigley H A. Neuronal death in glaucoma. Prog Retin Eye Res. 1999; 18: 39–57, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Pease M E, McKinnon S J, Quigley H A, Kerrigan-Baumrind L A, Zack D J. Obstructed axonal transport of BDNF and its receptor TrkB in experimental glaucoma. Invest Ophthalmol Vis Sci. 2000; 41: 764–774, [CSA]
   PubMed Web of Science ®Google Scholar
• Berkelaar M, Clarke D B, Wang Y C, Bray G M, Aguayo A J. Axotomy results in delayed death and apoptosis of retinal ganglion cells in adult rats. J Neurosci. 1994; 14: 4368–4374, [CSA]
   PubMed Web of Science ®Google Scholar
• Kermer P, Klocker N, Weishaupt J H, Bahr M. Transection of the optic nerve in rats: studying neuronal death and survival in vivo. Brain Res Brain Res Protoc. 2001; 7: 255–260, [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Levin L A, Clark J A, Johns L K. Effect of lipid peroxidation inhibition on retinal ganglion cell death. Invest Ophthalmol Vis Sci. 1996; 37: 2744–2749, [CSA]
   PubMed Web of Science ®Google Scholar
• Morimoto T, Miyoshi T, Fujikado T, Tano Y, Fukuda Y. Electrical stimulation enhances the survival of axotomized retinal ganglion cells in vivo. Neuroreport. 2002; 13: 227–230, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Morimoto T, Miyoshi T, Matsuda S, Tano Y, Fujikado T, Fukuda Y. Transcorneal electrical stimulation rescues axotomized retinal ganglion cells by activating endogenous retinal IGF-1 system. Invest Ophthalmol Vis Sci. 2005; 6: 2147–2155, [CSA], [CROSSREF]
   Google Scholar
• Kikuchi M, Tenneti L, Lipton S A. Role of p38 mitogen-activated protein kinase in axotomy-induced apoptosis of rat retinal ganglion cells. J Neurosci. 2000; 20: 5037–5044, [CSA]
   PubMed Web of Science ®Google Scholar
• Nakazawa T, Tomita H, Yamaguchi K, Sato Y, Shimura M, Kuwahara S, Tamai M. Neuroprotective effect of nipradilol on axotomized rat retinal ganglion cells. Curr Eye Res. 2002; 24: 114–122, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Hou B, You S W, Wu M M, Kuang F, Liu H L, Jiao X Y, Ju G. Neuroprotective effect of inosine on axotomized retinal ganglion cells in adult rats. Invest Ophthalmol Vis Sci. 2004; 45: 662–667, [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Wang J L, Liu D, Zhang Z J, Shan S, Han X, Srinivasula S M, Croce C M, Alnemri E S, Huang Z. Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells. Proc Natl Acad Sci USA. 2000; 13: 7124–7129, [CSA], [CROSSREF]
   Google Scholar
• Arias E, Gallego-Sandin S, Villarroya M, Garcia A G, Lopez M G. Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil and rivastigmine: role of nicotinic receptors of SH-SY5H neuroblastoma cells. J Pharmacol Exp Ther. 2005; 6: 1346–1353, [CSA], [CROSSREF]
   Google Scholar
• Hejmadi M V, Dajas-Bailador F, Barns S M, Jones B, Wonnacott S. Neuroprotection by nicotine against hypoxia-induced apoptosis in cortical cultures involves activation of multiple nicotinic acetylcholine receptor subtypes. Mol Cell Neurosci. 2003; 3: 779–786, [CSA], [CROSSREF]
   Google Scholar
• Yasuyoshi H, Kashii S, Kikuchi M, Zhang S, Honda Y, Akaike A. New insight into the functional role of acetylcholine in developing embryonic rat retinal neurons. Invest Ophthalmol Vis Sci. 2002; 43: 446–451, [CSA]
   PubMedGoogle Scholar
• Wehrwein E, Thompson S A, Coulibaly S F, Linn D M, Linn C L. Acetylcholine protection of adult pig retinal ganglion cells from glutamate-induced excitotoxicity. Invest Ophthalmol Vis Sci. 2004; 45: 1531–1543, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Pereira S P, Medina S V, Araujo E G. Cholinergic activity modulates the survival of retinal ganglion cells in culture: the role of M1 muscarinic receptors. Int J Dev Neurosci. 2001; 19: 559–567, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Sugimoto H, Iimura Y, Yamanishi Y, Yamatsu K. Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-benzyl-4-[(5,6-dimethoxy-1-oxoindan-2-yl)methyl] piperidine hydrochloride and related compounds. J Med Chem. 1995; 38: 4821–4829, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Wang X D, Chen X Q, Yang H H, Hu G Y. Comparison of the effects of cholinesterase inhibitors on [3H]MK-801 binding in rat cerebral cortex. Neurosci Lett. 1999; 272: 21–24, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Zhou J, Fu Y, Tang X C. Huperzine A and donepezil protect rat pheochromocytoma cells against oxygen-glucose deprivation. Neurosci Lett. 2001; 306: 53–56, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Snape M F, Misra A, Murray T K, De Souza R J, Williams J L, Cross A J, Green A R. A comparative study in rats of the in vitro and in vivo pharmacology of the acetylcholinesterase inhibitors tacrine, donepezil and NXX-066. Neuropharmacology. 1999; 38: 181–193, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Di Angelantonio S, Bernardi G, Mercuri N B. Donepezil modulates nicotinic receptors of substantia nigra dopaminergic neurones. Br J Pharmacol. 2004; 141: 644–652, [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Sortino M A, Frasca G, Chisari M, Platania P, Chiechio S, Vancheri C, Copani A, Canonico P L. Novel neuronal targets for the acetylcholinesterase inhibitor donepezil. Neuropharmacology. 2004; 47: 1198–1204, [CSA]
   PubMedGoogle Scholar
• Carmignoto G, Maffei L, Candeo P, Canella R, Comelli C. Effect of NGF on the survival of rat retinal ganglion cells following optic nerve section. J Neurosci. 1989; 4: 1263–1272, [CSA]
   Google Scholar
• Mey J, Thanos S. Intravitreal injections of neurotrophic factors support the survival of axotomized retinal ganglion cells in adult rats in vivo. Brain Res. 1993; 2: 304–317, [CSA], [CROSSREF]
   Google Scholar
• Mansour-Robaey S, Clarke D B, Wang Y C, Bray G M, Aguayo A J. Effects of ocular injury and administration of brain-derived neurotrophic factor on survival and regrowth of axotomized retinal ganglion cells. Proc Natl Acad Sci USA. 1994; 5: 1632–1636, [CSA]
   Google Scholar
• Klocker N, Braunling F, Isenmann S, Bahr M. In vivo neurotrophic effects of GDNF on axotomized retinal ganglion cells. Neuroreport. 1997; 16: 3439–3442, [CSA]
   Google Scholar
• Kermer P, Klocker N, Labes M, Bahr M. Insulin-like growth factor-I protects axotomized rat retinal ganglion cells from secondary death via PI3-K-dependent Akt phosphorylation and inhibition of caspase-3 in vivo. J Neurosci. 2000; 2: 2–8, [CSA]
   Google Scholar
• Dunn N R, Pearce G L, Shakir S A. Adverse effects associated with the use of donepezil in general practice in England. J Psychopharmacol. 2000; 4: 406–408, [CSA]
   Google Scholar